Home » Topics » Regulatory » Patents

Patents
RSS

Lamivudine prodrugs targeting macrophages reported by European investigators

Nov. 24, 1998

Synthelabo describes new series of serotonergic antagonists

Nov. 24, 1998

Antiinflammatory tetrazoles in development at Ono

Nov. 23, 1998

Merck & Co. presents potent and selective sst2 receptor agonists

Nov. 23, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

New MRI contrast agents with favorable neurotoxicity profile developed at Bracco

Nov. 23, 1998

Osteoclast differentiation inhibitors for arthritis under study at Sumitomo

Nov. 23, 1998

Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Erythromycin derivatives with high activity against sensitive and resistant microorganisms

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...